comparemela.com

Latest Breaking News On - Target vessel revascularization - Page 1 : comparemela.com

Ticagrelor Alone Cuts Bleeding Without More Events Post-PCI

Ticagrelor monotherapy safely cut bleeding by more than half after intervention for acute coronary syndrome, without an increase in MACCE, in the ULTIMATE-DAPT trial.

United-kingdom
Nanjing
Jiangsu
China
Vienna
Wien
Austria
Italy
New-york
United-states
Virginia
Pakistan

Post-PCI FFR in Multivessel Disease Predicts Target Vessel Failure

In a new analysis of the FAME 3 trial, post-PCI fractional flow reserve predicted both target vessel failure and the risk of cardiac events.

Boston
Massachusetts
United-states
Budapest
Hungary
Zsolt-piroth
Gottsegen-institute-of-cardiology
Brown-university
Boston-scientific
Medtronic
Philips
Gottsegen-institute

QFR-Guided PCI Benefits Build Over Time: FAVOR III China

The sham-controlled study found clinical outcomes improved incrementally over time, compared with PCI guided by angiographic assessment of lesions.

Boston
Massachusetts
United-states
Beijing
China
Italy
Toronto
Ontario
Canada
Peking
Sunnybrook
Alberta

vimarsana © 2020. All Rights Reserved.